FDAzilla GMP Regulatory Intelligence Newsletter

FDAzilla GMP Regulatory Intelligence Newsletter
FDAzilla GMP Regulatory Intelligence Newsletter2019-01-24T16:12:39+00:00

Latest Issue

WEEKLY SCAN | April 14, 2019

A handful of guidance this week from FDA, EMA and Health Canada.  We provide the usual collection of non-guidance publications from the EMA, FDA, MHRA, HPRA, WHO and the Netherlands MEB. Enforcement included two drug warning letters to pharma firms, and one to a compounding pharmacy.  This rounded out with a collection of recalls and import alerts.  Nothing from Europe or Canada this week. Some interesting reading in the weekly scan at the end. Happy Reading, Barb FDA: [...]

By |April 20th, 2019|Categories: Weekly Scans|0 Comments

Special Reports

January 22nd, 2019|0 Comments

A detailed summary of the drug GMP warning letters issued in FY2018, as well as a comparison of trends [...]

January 8th, 2019|0 Comments

RISK FACTORS USED IN SCHEDULING FDA DRUG GMP INSPECTIONS The global supply chain for drug products sold in the [...]

July 16th, 2018|0 Comments

Warning Letters for the First Half of 2018 This article summarizes warning letter enforcement actions in the first half of [...]

Archive